---
$id: https://graph.org.ai/products/commodity/51282323
$type: Product
source: UNSPSC
code: "51282323"
title: "Erythromycin oxime"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Erythromycin oxime

**UNSPSC Code**: 51282323
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic C37H68N2O13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 10W452CMTZ, chemically known as erythromycin, 9-oxime, but more generally known as erythromycin oxime, which bears US NIH Compound Identifier 6537896. Most nations, for tariff and trade purposes, schedule erythromycin oxime under HS 29415000 and SITC 54139. As of Q4 2014, ERYTHROMYCIN OXIME remains US FDA's Preferred Term for this commodity. Erythromycin oxime bears US NLM identifiers UMLS ID C0207096 and NCI Concept Code C87758. SMILES: CC[C@@H]1[C@@]([C@@H]([C@H](C(=NO)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O.

